Researchers used cryo-EM, glycoproteomics, and modeling to generate the atomic structure of a fully glycosylated and membrane ...

Jan. 30, 2025 — The antibody targets a stable part of the bird flu virus, ensuring that the immune ... the first season following the approval of RSV vaccines. The vaccine effectively prevented ...

The human respiratory syncytial virus (HRSV) is one of the main agents of bronchiolitis ... since the two viruses have similar virion structure and genome organisation (5, 6). Like HCV, BVDV utilizes ...

Learn to recognize dangerous RSV symptoms in children beyond typical cold signs, including breathing changes, distinctive ...

Participants were observed for two seasons, from August 31, 2021, to December 18, 2023, to evaluate vaccine efficacy, its safety and the increase in antibody levels against RSV-A and RSV-B variants.

Variations in temperature, precipitation, and humidity can influence the spread of infectious diseases, including by altering ...

Insect miRNAs can be transferred to their host plants upon feeding. This study shows that a conserved insect microRNA plays a ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

For over a century, scientists have analyzed the vast microbial world within the human body. They’ve found bacteria, fungi, ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

A separate committee at the CDC was scheduled to meet in February to make important decisions on vaccines for meningococcal, respiratory syncytial virus (RSV), human papillomavirus (HPV ...